MKC.V compared with PDSB: revenue, margins and what each company keeps, and the suppliers and customers both name

MKC.VMcCormick & Co., Inc.

Mkt capRevenueRevenue

PDSBPDS Biotechnology Corp

Mkt capRevenueRevenue

Compare

MKC.VMcCormick & Co., Inc.

PDSBPDS Biotechnology Corp

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

MKC.V

No earnings history for MKC.V.

PDSB1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−3.64%—

= impliedMKC.V realized, solidPDSB realized, hatchedOne scale, both sides: full bar = 4%× = |realized| ÷ impliedSource: market data

MKC.VMcCormick & Co., Inc.

51.18▲+2.18%· post 48.38

Mkt cap$13.0BRevenue$2.0BQ3 FY26Revenue$6.8BFY25

PDSBPDS Biotechnology Corp

1.23▲+5.13%· post 1.21

ClosedNov 6 '26

Mkt cap$68.8MRevenue—Revenue—

Compare

ClosedNov 6 '26

MKC.VMcCormick & Co., Inc.

PDSBPDS Biotechnology Corp

51.18▲+2.18%post 48.38

Price

1.23▲+5.13%post 1.21

$13.0B

Mkt cap

$68.8M

Q3 FY26$2.0B

Revenue

—

FY25$6.8B

Revenue

—

MKC.V51.18▲+2.18%vsPDSB1.23▲+5.13%ClosedNov 6 '26